IDEX Corporation provided earnings guidance for the year 2022. For the period, the company's organic sales growth is projected to be approximately 12% over the prior year period, with a 9 % organic sales increase in the fourth quarter of 2022 versus the prior year period. The Company expects full year 2022 reported EPS attributable to IDEX of $7.75 to $7.80 (adjusted EPS attributable to IDEX of $8.04 to $8.09).
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
206.1 USD | -1.21% | -4.20% | -5.07% |
05-16 | IDEX Biometrics Completes Upsized NOK55 Million Share Placement | MT |
05-08 | Declaration of Voting Results by IDEX Corporation | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.07% | 15.6B | |
-8.69% | 13.4B | |
+17.08% | 6.35B | |
-8.38% | 5.01B | |
+1.26% | 4.51B | |
+5.81% | 3.09B | |
+81.50% | 1.7B | |
+4.51% | 1.29B | |
+15.21% | 988M | |
-0.37% | 928M |
- Stock Market
- Equities
- IEX Stock
- News IDEX Corporation
- Idex Corporation Provides Earnings Guidance for the Year 2022